Canada vs Congo: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Canada
85.0%
in 2025
Congo
85.0%
in 2025
Canada rank
96th
Congo rank
96th
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Canada
- Congo
How they compare
Canada currently reports 85.0% against 85.0% in Congo, a difference of 0.0%.
The two have swapped places 3 times across 18 shared years of data; in 2008 it was Canada ahead.
Canada ranks 96th and Congo ranks 96th of 194 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 46.0% | 0.0% | 46.0% | Canada |
| 2010s | 76.1% | 53.4% | 22.7% | Canada |
| 2020s | 84.7% | 77.5% | 7.2% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Canada or Congo?
- Canada, at 85.0% against 85.0% in Congo as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Canada and Congo?
- 0.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Congo?
- 18 years are reported by both, from 2008 to 2025.
- How do Canada and Congo rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Canada ranks 96th and Congo ranks 96th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.